Disturbance of HDL apolipoprotein AI metabolism in severe hyperlipidemic and lipodystrophic HIV patients on a protease inhibitor treatment

Por Ouguerram, Khadija, Zair, Yassine, Billon, Stéphanie, krempf, Michel
Publicado em 2010

Cholesterol lowering effect of a soy drink enriched with plant sterols in a French population with moderate hypercholesterolemia

Por Weidner, Christina, Krempf, Michel, Bard, Jean-Marie, Cazaubiel, Murielle, Bell, Doris
Publicado em 2008

Omega 3 Fatty Acids Promote Macrophage Reverse Cholesterol Transport in Hamster Fed High Fat Diet

Por Kasbi Chadli, Fatima, Nazih, Hassane, Krempf, Michel, Nguyen, Patrick, Ouguerram, Khadija
Publicado em 2013

Efficacy of alirocumab according to background statin type and dose: pooled analysis of 8 ODYSSEY Phase 3 clinical trials

Por Catapano, Alberico L., Lee, L. Veronica, Louie, Michael J., Thompson, Desmond, Bergeron, Jean, Krempf, Michel
Publicado no Sci Rep (2017)

Multiplexed peptide analysis for kinetic measurements of major human apolipoproteins by LC/MS/MS

Por Croyal, Mikaël, Fall, Fanta, Ferchaud-Roucher, Véronique, Chétiveaux, Maud, Zaïr, Yassine, Ouguerram, Khadija, Krempf, Michel, Nobécourt, Estelle
Publicado no J Lipid Res (2016)

Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults

Por Cariou, Bertrand, Chetiveaux, Maud, Zaïr, Yassine, Pouteau, Etienne, Disse, Emmanuel, Guyomarc'h-Delasalle, Béatrice, Laville, Martine, Krempf, Michel
Publicado em 2011

IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens

Por Charpentier, Maud, Croyal, Mikael, Carbonnelle, Delphine, Fortun, Agnès, Florenceau, Laetitia, Rabu, Catherine, Krempf, Michel, Labarrière, Nathalie, Lang, François
Publicado no Oncotarget (2016)

Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey

Por Krempf, Michel, Simpson, Ross J, Ramey, Dena Rosen, Brudi, Philippe, Giezek, Hilde, Tomassini, Joanne E, Lee, Raymond, Farnier, Michel
Publicado no Lipids Health Dis (2015)

Nicotinic Acid Accelerates HDL Cholesteryl Ester Turnover in Obese Insulin-Resistant Dogs

Por Le Bloc'h, Jérôme, Leray, Véronique, Nazih, Hassan, Gauthier, Olivier, Serisier, Samuel, Magot, Thierry, Krempf, Michel, Nguyen, Patrick, Ouguerram, Khadija
Publicado no PLoS One (2015)

Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of...

Por Kastelein, John J. P., Robinson, Jennifer G., Farnier, Michel, Krempf, Michel, Langslet, Gisle, Lorenzato, Christelle, Gipe, Daniel A., Baccara-Dinet, Marie T.
Publicado em 2014

Plasma PCSK9 concentrations during an oral fat load and after short term high-fat, high-fat high-protein and high-fructose diets

Por Cariou, Bertrand, Langhi, Cédric, Le Bras, Maëlle, Bortolotti, Murielle, Lê, Kim-Anne, Theytaz, Fanny, Le May, Cédric, Guyomarc’h-Delasalle, Béatrice, Zaïr, Yassine, Kreis, Roland, Boesch, Chris, Krempf, Michel, Tappy, Luc, Costet, Philippe
Publicado em 2013

Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study

Por Blanchard, Valentin, Ramin-Mangata, Stéphane, Billon-Crossouard, Stéphanie, Aguesse, Audrey, Durand, Manon, Chemello, Kevin, Nativel, Brice, Flet, Laurent, Chétiveaux, Maud, Jacobi, David, Bard, Jean-Marie, Ouguerram, Khadija, Lambert, Gilles, Krempf, Michel, Croyal, Mikaël
Publicado no J Lipid Res (2018)

A fourth locus for autosomal dominant hypercholesterolemia maps at 16q22.1

Por Marques-Pinheiro, Alice, Marduel, Marie, Rabès, Jean-Pierre, Devillers, Martine, Villéger, Ludovic, Allard, Delphine, Weissenbach, Jean, Guerin, Maryse, Zair, Yassine, Erlich, Danièle, Junien, Claudine, Munnich, Arnold, Krempf, Michel, Abifadel, Marianne, Jaïs, Jean-Philippe, Boileau, Catherine, Varret, Mathilde
Publicado em 2010

Consequences of blunting the mevalonate pathway in cancer identified by a pluri-omics approach

Por Goulitquer, Sophie, Croyal, Mikaël, Lalande, Julie, Royer, Anne-Lise, Guitton, Yann, Arzur, Danielle, Durand, Stéphanie, Le Jossic-Corcos, Catherine, Bouchereau, Alain, Potin, Philippe, Akoka, Serge, Antignac, Jean-Philippe, Krempf, Michel, Ferchaud-Roucher, Véronique, Giraudeau, Patrick, Corcos, Laurent
Publicado no Cell Death Dis (2018)

ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia

Por Kastelein, John J.P., Ginsberg, Henry N., Langslet, Gisle, Hovingh, G. Kees, Ceska, Richard, Dufour, Robert, Blom, Dirk, Civeira, Fernando, Krempf, Michel, Lorenzato, Christelle, Zhao, Jian, Pordy, Robert, Baccara-Dinet, Marie T., Gipe, Daniel A., Geiger, Mary Jane, Farnier, Michel
Publicado no Eur Heart J (2015)

PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo: An Effect Blunted by Alirocumab

Por Villard, Elise F., Thedrez, Aurélie, Blankenstein, Jorg, Croyal, Mikaël, Tran, Thi-Thu-Trang, Poirier, Bruno, Le Bail, Jean-Christophe, Illiano, Stéphane, Nobécourt, Estelle, Krempf, Michel, Blom, Dirk J., Marais, A. David, Janiak, Philip, Muslin, Anthony J., Guillot, Etienne, Lambert, Gilles
Publicado no JACC Basic Transl Sci (2016)

Residual macrovascular risk in 2013: what have we learned?

Por Fruchart, Jean-Charles, Davignon, Jean, Hermans, Michel P, Al-Rubeaan, Khalid, Amarenco, Pierre, Assmann, Gerd, Barter, Philip, Betteridge, John, Bruckert, Eric, Cuevas, Ada, Farnier, Michel, Ferrannini, Ele, Fioretto, Paola, Genest, Jacques, Ginsberg, Henry N, Gotto, Antonio M, Hu, Dayi, Kadowaki, Takashi, Kodama, Tatsuhiko, Krempf, Michel, Matsuzawa, Yuji, Núñez-Cortés, Jesús Millán, Monfil, Carlos Calvo, Ogawa, Hisao, Plutzky, Jorge, Rader, Daniel J, Sadikot, Shaukat, Santos, Raul D, Shlyakhto, Evgeny, Sritara, Piyamitr, Sy, Rody, Tall, Alan, Tan, Chee Eng, Tokgözoğlu, Lale, Toth, Peter P, Valensi, Paul, Wanner, Christoph, Zambon, Alberto, Zhu, Junren, Zimmet, Paul
Publicado em 2014

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody

Por Hopkins, Paul N., Defesche, Joep, Fouchier, Sigrid W., Bruckert, Eric, Luc, Gérald, Cariou, Bertrand, Sjouke, Barbara, Leren, Trond P., Harada-Shiba, Mariko, Mabuchi, Hiroshi, Rabès, Jean-Pierre, Carrié, Alain, van Heyningen, Charles, Carreau, Valérie, Farnier, Michel, Teoh, Yee P., Bourbon, Mafalda, Kawashiri, Masa-aki, Nohara, Atsushi, Soran, Handrean, Marais, A. David, Tada, Hayato, Abifadel, Marianne, Boileau, Catherine, Chanu, Bernard, Katsuda, Shoji, Kishimoto, Ichiro, Lambert, Gilles, Makino, Hisashi, Miyamoto, Yoshihiro, Pichelin, Matthieu, Yagi, Kunimasa, Yamagishi, Masakazu, Zair, Yassine, Mellis, Scott, Yancopoulos, George D., Stahl, Neil, Mendoza, Johanna, Du, Yunling, Hamon, Sara, Krempf, Michel, Swergold, Gary D.
Publicado no Circ Cardiovasc Genet (2015)